Incyte Corp
Change company Symbol lookup
Select an option...
INCY Incyte Corp
TRMD Torm PLC
THC Tenet Healthcare Corp
BKCC BlackRock Capital Investment Corp
VIR Vir Biotechnology Inc
CBH Virtus Convertible & Income 2024 Target Term Fund
PSX Phillips 66
RGT Royce Global Value Trust
ROSEW Rose Hill Acquisition Equity Warrant Exp 07th Oct 2026 *W EXP 10/07/2026
EDR Endeavor Group Holdings Inc
Go

Health Care : Biotechnology | Mid Cap Growth
Company profile

Incyte Corporation is a biopharmaceutical company, which is focused on the discovery, development, and commercialization of therapeutics. The Company also conducts commercial and clinical development operations from its European headquarters in Morges, Switzerland, and Japanese office in Tokyo and Canadian headquarters in Montreal. It operates in two therapeutic areas, One therapeutic area is Hematology/Oncology, which is comprised of Myeloproliferative Neoplasms and Graft-Versus-Host Disease, as well as solid tumors and hematologic malignancies. The other therapeutic area is Inflammation and Autoimmunity, which includes its Dermatology commercial franchise. Its hematology and oncology franchise is comprised of four products, which are JAKAFI (ruxolitinib), MONJUVI (tafasitamab-cxix)/MINJUVI (tafasitamab), PEMAZYRE (pemigatinib) and ICLUSIG (ponatinib), as well as other clinical development programs. Its Dermatology commercial franchise is comprised of OPZELURA (ruxolitinib) cream.

Premarket

Last Trade
Delayed
$78.23
-1.02 (-1.29%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$79.25
Day's Change
0.00 (0.00%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
3

10-day average volume:
1,514,896
3
  • Prev Close
    79.25
  • Today's Open
    --
  • Day's Range
    --
  • Avg Vol (10-day)
    1.5M
  • Last (time)
    4:00p ET 07/05/22
  • Last (size)
    2
  • 52-Wk Range
    61.91 - 84.86
    LowHigh
  • (11/02/21 - 04/08/22)
    6.61%
  • 30.1%
  • Market Cap
    17.6B
  • Shares Outstanding
    221.5M
  • 4.20
  • 18.49x
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.7
  • 94.30
  • (% of float 06/15/22)
    3.02

Latest News

July 05, 2022
5:00 pm ET
MarketWatch
July 01, 2022
5:00 pm ET
MarketWatch
June 30, 2022
4:59 pm ET
MarketWatch
June 29, 2022
5:00 pm ET
MarketWatch
June 28, 2022
5:00 pm ET
MarketWatch
June 27, 2022
5:00 pm ET
MarketWatch
June 24, 2022
4:59 pm ET
MarketWatch
June 23, 2022
4:59 pm ET
MarketWatch
June 22, 2022
5:00 pm ET
MarketWatch
June 21, 2022
4:59 pm ET
MarketWatch
June 17, 2022
4:59 pm ET
MarketWatch
June 16, 2022
5:00 pm ET
MarketWatch
June 15, 2022
4:59 pm ET
MarketWatch
June 14, 2022
4:59 pm ET
MarketWatch
June 13, 2022
9:50 pm ET
PR Newswire
4:59 pm ET
MarketWatch
4:01 pm ET
BusinessWire
June 10, 2022
4:59 pm ET
MarketWatch
June 09, 2022
5:00 pm ET
MarketWatch
June 08, 2022
4:59 pm ET
MarketWatch
June 07, 2022
4:59 pm ET
MarketWatch
June 06, 2022
4:59 pm ET
MarketWatch
June 03, 2022
4:59 pm ET
MarketWatch
June 02, 2022
4:59 pm ET
MarketWatch
June 01, 2022
4:59 pm ET
MarketWatch
May 31, 2022
4:59 pm ET
MarketWatch
May 27, 2022
4:59 pm ET
MarketWatch
May 26, 2022
5:00 pm ET
MarketWatch
6:00 am ET
BusinessWire
May 25, 2022
4:59 pm ET
MarketWatch
May 24, 2022
5:00 pm ET
MarketWatch
8:00 am ET
BusinessWire
May 23, 2022
4:59 pm ET
MarketWatch
May 20, 2022
4:59 pm ET
MarketWatch
8:11 am ET
PR Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.